中文 | English
Return
Total: 100 , 1/10
Show Home Prev Next End page: GO
Author:(Jifeng LI)

1.Reversal for acquired resistance to EGFR inhibitors in lung cancer

Chenchen LI ; Jifeng FENG

Journal of International Oncology 2013;40(11):843-846

2.Diagnosis and treatment of primary central nervous system lymphoma

Xiaoyou LI ; Jifeng FENG

Journal of International Oncology 2013;40(8):621-624

3.Application of corresponding analysis in study on trace elements of Chinese materia medica

Jifeng LI ; Jinhong GAO

Chinese Traditional and Herbal Drugs 1994;0(12):-

4.Investigation of the emergency situation for agency of disease prevention and control in Xi′an

Qinli LI ; Jifeng LIU

Chinese Journal of Primary Medicine and Pharmacy 2015;(16):2517-2520

5.Treatment of primary central nervous system lymphoma

Xiaoyou LI ; Jifeng FENG

Journal of International Oncology 2016;43(1):71-74

6.Effect of dexmedetomidine on long-term cognitive function after partial hepatectomy in mice

Jifeng LI ; Zhiguo LI ; Xihai WANG

The Journal of Clinical Anesthesiology 2016;(2):166-170

7.Influence on curative effect of aescin in curing Lumbar intervertebral disc prolapse(LIDP) before and after operation

Qinggong GUO ; Zhigang LIU ; Jifeng LI ;

Chinese Traditional Patent Medicine 1992;0(10):-

8.The expression of 5-HT in normal lymph-node and lymphoma of human

Jifeng LI ; Zhou WANG ; Wiangrui JI

Chinese Journal of Immunology 1985;0(01):-

9.Carotid intima-media thickness and uric acid level and the research of the prognosis of patients with coronary heart disease

Jifeng LI ; Shaowan CHEN ; Yuyang CHEN

Chinese Journal of Primary Medicine and Pharmacy 2015;22(9):1358-1360

10.Effects of enhanced external counterpulsation in treatment of the hypertensive patients with diastolic heart failure

Zhijian PENG ; Jiansheng CAI ; Bingqin LIN ; Jifeng LI ; Shaobo ZHANG

Chinese Journal of Primary Medicine and Pharmacy 2008;15(12):1954-1955

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 100 , 1/10 Show Home Prev Next End page: GO